260 related articles for article (PubMed ID: 26970204)
1. Immunogenic properties of trivalent recombinant protein composed of B-subunits of LT, STX-2, and CT toxins.
Kazemi R; Akhavian A; Amani J; Salimian J; Motamedi MJ; Mousavi A; Jafari M; Salmanian AH
Microbes Infect; 2016 Jun; 18(6):421-429. PubMed ID: 26970204
[TBL] [Abstract][Full Text] [Related]
2. A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.
Ruan X; Liu M; Casey TA; Zhang W
Clin Vaccine Immunol; 2011 Oct; 18(10):1593-9. PubMed ID: 21813665
[TBL] [Abstract][Full Text] [Related]
3. Immunization against Vibrio cholerae, ETEC, and EHEC with chitosan nanoparticle containing LSC chimeric protein.
Ghaffari Marandi BH; Zolfaghari MR; Kazemi R; Motamedi MJ; Amani J
Microb Pathog; 2019 Sep; 134():103600. PubMed ID: 31202906
[TBL] [Abstract][Full Text] [Related]
4. Escherichia coli K88ac fimbriae expressing heat-labile and heat-stable (STa) toxin epitopes elicit antibodies that neutralize cholera toxin and STa toxin and inhibit adherence of K88ac fimbrial E. coli.
Zhang C; Zhang W
Clin Vaccine Immunol; 2010 Dec; 17(12):1859-67. PubMed ID: 20980482
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a fusion protein comprising coli surface antigen 3 and labile B subunit of enterotoxigenic Escherichia coli.
Alerasol M; Mousavi Gargari SL; Nazarian S; Bagheri S
Iran Biomed J; 2014; 18(4):212-218. PubMed ID: 25326019
[TBL] [Abstract][Full Text] [Related]
6. Significance of Enterotoxigenic Escherichia coli (ETEC) Heat-Labile Toxin (LT) Enzymatic Subunit Epitopes in LT Enterotoxicity and Immunogenicity.
Huang J; Duan Q; Zhang W
Appl Environ Microbiol; 2018 Aug; 84(15):. PubMed ID: 29802193
[TBL] [Abstract][Full Text] [Related]
7. Protection of mice against enterotoxigenic E. coli by immunization with a polyvalent enterotoxin comprising a combination of LTB, STa, and STb.
You J; Xu Y; He M; McAllister TA; Thacker PA; Li X; Wang T; Jin L
Appl Microbiol Biotechnol; 2011 Mar; 89(6):1885-93. PubMed ID: 21085949
[TBL] [Abstract][Full Text] [Related]
8. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
[TBL] [Abstract][Full Text] [Related]
9. A Chimeric protein of CFA/I, CS6 subunits and LTB/STa toxoid protects immunized mice against enterotoxigenic Escherichia coli.
Zeinalzadeh N; Salmanian AH; Goujani G; Amani J; Ahangari G; Akhavian A; Jafari M
Microbiol Immunol; 2017 Jul; 61(7):272-279. PubMed ID: 28543534
[TBL] [Abstract][Full Text] [Related]
10. The immunogenicity of fusion protein linking the carboxyl terminus of the B subunit of Shiga toxin 2 to the B subunit of E. coli heat-labile enterotoxin.
Ran XQ; Wang HZ; Liu JJ; Li S; Wang JF
Vet Microbiol; 2008 Feb; 127(1-2):209-15. PubMed ID: 17920213
[TBL] [Abstract][Full Text] [Related]
11. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
[TBL] [Abstract][Full Text] [Related]
12. Recombinant HcpA-EspA-Tir-Stx2B chimeric protein induces immunity against attachment and toxicity of Escherichia coli O157:H7.
Kordbacheh E; Nazarian S; Hajizadeh A; Fasihi-Ramandi M; Fathi J
Microb Pathog; 2019 Apr; 129():176-182. PubMed ID: 30731187
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice.
Zhang XH; He KW; Zhang SX; Lu WC; Zhao PD; Luan XT; Ye Q; Wen LB; Li B; Guo RL; Wang XM; Lv LX; Zhou JM; Yu ZY; Mao AH
Vaccine; 2011 May; 29(22):3923-9. PubMed ID: 21338683
[TBL] [Abstract][Full Text] [Related]
14. Heat-labile- and heat-stable-toxoid fusions (LTR₁₉₂G-STaP₁₃F) of human enterotoxigenic Escherichia coli elicit neutralizing antitoxin antibodies.
Liu M; Ruan X; Zhang C; Lawson SR; Knudsen DE; Nataro JP; Robertson DC; Zhang W
Infect Immun; 2011 Oct; 79(10):4002-9. PubMed ID: 21788385
[TBL] [Abstract][Full Text] [Related]
15. Construction and evaluation of a fluorescence-based live attenuated Escherichia coli delivery system for generating oral vaccine candidate.
Liu W; Li X; Bao J; Guan W; Zhao Z; Yuan C; Tang J; Shi D
Appl Microbiol Biotechnol; 2015 May; 99(9):4005-18. PubMed ID: 25567512
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.
Lundgren A; Leach S; Tobias J; Carlin N; Gustafsson B; Jertborn M; Bourgeois L; Walker R; Holmgren J; Svennerholm AM
Vaccine; 2013 Feb; 31(8):1163-70. PubMed ID: 23306362
[TBL] [Abstract][Full Text] [Related]
17. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.
Tokuhara D; Yuki Y; Nochi T; Kodama T; Mejima M; Kurokawa S; Takahashi Y; Nanno M; Nakanishi U; Takaiwa F; Honda T; Kiyono H
Proc Natl Acad Sci U S A; 2010 May; 107(19):8794-9. PubMed ID: 20421480
[TBL] [Abstract][Full Text] [Related]
18. Functional pentameric formation via coexpression of the Escherichia coli heat-labile enterotoxin B subunit and its fusion protein subunit with a neutralizing epitope of ApxIIA exotoxin improves the mucosal immunogenicity and protection against challenge by Actinobacillus pleuropneumoniae.
Kim JM; Park SM; Kim JA; Park JA; Yi MH; Kim NS; Bae JL; Park SG; Jang YS; Yang MS; Kim DH
Clin Vaccine Immunol; 2011 Dec; 18(12):2168-77. PubMed ID: 22030372
[TBL] [Abstract][Full Text] [Related]
19. Construction and immunogenic properties of a chimeric protein comprising CfaE, CfaB and LTB against Enterotoxigenic Escherichia coli.
Gheibi Hayat SM; Mousavi Gargari SL; Nazarian S
Biologicals; 2016 Nov; 44(6):503-510. PubMed ID: 27733309
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the A-Subunit of the Heat-Labile Toxin (LT) As an Immunogen and a Protective Antigen Against Enterotoxigenic Escherichia coli (ETEC).
Norton EB; Branco LM; Clements JD
PLoS One; 2015; 10(8):e0136302. PubMed ID: 26305793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
